Clinical Trials in Illinois

Showing 8721-8740 of 19,692 trials

Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

NCT03370185

This is a multi-center, single-arm, open-label, Phase 2 study of duvelisib, an orally bioavailable dual inhibitor of PI3K-δ,γ, in patients with CLL/SLL who have previously been treated with ibrutinib or another Bruton's Tyrosine Kinase Inhibitor (BTKi) and relapsed or were refractory to such therapy or discontinued such therapy due to toxicity.

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

SecuraBioStarted Feb 2018

Tempe, Arizona, United States • Hot Springs, Arkansas, United States • La Jolla, California, United States +5 more locations

COMPLETEDPhase 2125 miles

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

NCT01430442

The primary purpose of this study is to evaluate the efficacy of rimegepant (BMS-927711) compared with placebo in the acute treatment of migraine as measured by Pain Freedom (headache pain intensity level reported as "no pain") at 2 hours post dose using a four point numeric rating scale (no pain, mild pain, moderate pain, severe pain) while identifying an optimal dose to support the Phase 3 clinical trials.

MigraineAcute Treatment of Migraine

Pfizer1,026 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Tempe, Arizona, United States • San Francisco, California, United States +38 more locations

Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Find Trials by Condition in Illinois

Expanded Access Protocol Using 131I-MIBG

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer

MS PATHS Normative Sub-Study

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest

A Study of ADXS-NEO Expressing Personalized Tumor Antigens